Epilepsy, idiopathic generalized, susceptibility to, 13: genes and variants

Epilepsy, idiopathic generalized, susceptibility to, 13 is linked to 6 analyzed proteins (GABRA1, CASR, SLC2A1, ZFHX3, HCN4 and KCNMA1). 37 DNA variants are known to cause it; 299 more are uncertain, and 4 of those already look disease-causing on computable evidence.

Last updated 2026-09-30. Research information, not medical advice.

Also known as: Epilepsy, idiopathic generalized 20; Epilepsy, idiopathic generalized, susceptibility to, 12; Epilepsy, idiopathic generalized, susceptibility to, 16; Epilepsy, idiopathic generalized, susceptibility to, 18; Epilepsy, idiopathic generalized, susceptibility to, 8

Genes linked to Epilepsy, idiopathic generalized, susceptibility to, 13

Where Epilepsy, idiopathic generalized, susceptibility to, 13 variants cluster

Known disease-causing variants in Epilepsy, idiopathic generalized, susceptibility to, 13

VariantPositionProtein partClinical label
CASR E127K127Ligand-binding 1 (LB1)Disease-causing (★★)
GABRA1 R214C214ExtracellularDisease-causing (★★)
CASR E127A127Ligand-binding 1 (LB1)Disease-causing (★★)
GABRA1 R214H214ExtracellularDisease-causing (★★)
CASR L125P125Ligand-binding 1 (LB1)Disease-causing (★★)
CASR R220W220Ligand-binding 2 (LB2)Disease-causing (★★)
GABRA1 T289A289TransmembraneDisease-causing (★★)
GABRA1 R147Q147ExtracellularDisease-causing (★★)
SLC2A1 R223W223CytoplasmicDisease-causing (★★)
SLC2A1 R458W458CytoplasmicDisease-causing (★★)
GABRA1 T295I295TransmembraneDisease-causing (★★)
SLC2A1 R223P223CytoplasmicDisease-causing (★★)
CASR R66C66Ligand-binding 1 (LB1)Disease-causing (★★)
CASR V689M689TransmembraneDisease-causing (★★)
CASR R227Q227Ligand-binding 2 (LB2)Disease-causing (★★)
GABRA1 P124L124ExtracellularDisease-causing (★)
GABRA1 T292I292TransmembraneDisease-causing (★)
GABRA1 S213T213ExtracellularDisease-causing (★)
GABRA1 E277G277CytoplasmicDisease-causing (★)
GABRA1 F42L42ExtracellularDisease-causing (★)
GABRA1 F92S92ExtracellularDisease-causing (★)
GABRA1 Y187D187ExtracellularDisease-causing (★)
GABRA1 G251S251ExtracellularDisease-causing (★)
GABRA1 Y252C252ExtracellularDisease-causing (★)
GABRA1 M263T263TransmembraneDisease-causing (★)
GABRA1 L267F267TransmembraneDisease-causing (★)
GABRA1 N275K275CytoplasmicDisease-causing (★)
GABRA1 T288I288TransmembraneDisease-causing (★)
GABRA1 F325L325TransmembraneDisease-causing (★)
GABRA1 Q28H28ExtracellularDisease-causing (★)
GABRA1 I45T45ExtracellularDisease-causing (★)
GABRA1 A188D188ExtracellularDisease-causing (★)
GABRA1 P280Q280TransmembraneDisease-causing (★)
SLC2A1 M420I420TransmembraneDisease-causing (★)
CASR E191K191Ligand-binding 2 (LB2)Disease-causing (★)
GABRA1 R2K2Disease-causing (★)
ZFHX3 P3618Q3618Disease-causing

Uncertain variants in Epilepsy, idiopathic generalized, susceptibility to, 13 that look disease-causing

VariantPositionProtein partClinical labelEvidence
GABRA1 R214S214ExtracellularConflicting reports (★)+6: 3 other pathogenic changes within 3 positions; R214H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89
GABRA1 N275S275CytoplasmicUncertain (★★)+6: 2 other pathogenic changes within 3 positions; N275K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.65
GABRA1 Y187F187ExtracellularUncertain (★)+6: 2 other pathogenic changes within 3 positions; Y187D at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.729
GABRA1 E277D277CytoplasmicUncertain (★)+6: 3 other pathogenic changes within 3 positions; E277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95

Which prediction tools work for Epilepsy, idiopathic generalized, susceptibility to, 13

How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).

Same protein, different disease

Diseases related to Epilepsy, idiopathic generalized, susceptibility to, 13

Frequently asked questions

Which genes are linked to Epilepsy, idiopathic generalized, susceptibility to, 13?

In CATVariant, Epilepsy, idiopathic generalized, susceptibility to, 13 is linked to 6 analyzed proteins: GABRA1 (Gamma-aminobutyric acid receptor subunit alpha-1), CASR (Extracellular calcium-sensing receptor), SLC2A1 (Solute carrier family 2, facilitated glucose transporter member 1), ZFHX3 (Zinc finger homeobox protein 3), HCN4 (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) and KCNMA1 (Calcium-activated potassium channel subunit alpha-1).

How many genetic variants are linked to Epilepsy, idiopathic generalized, susceptibility to, 13?

354 variants: 37 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 299 are of uncertain significance or have conflicting reports.

Which uncertain variants in Epilepsy, idiopathic generalized, susceptibility to, 13 look disease-causing?

4 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example GABRA1 R214S, GABRA1 N275S, GABRA1 Y187F and GABRA1 E277D. These are leads for expert review, not diagnoses.

Which variant effect predictor works best for Epilepsy, idiopathic generalized, susceptibility to, 13?

Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.87, based on 11 disease-causing and 110 harmless variants).

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center